SLL

What Small Lymphocytic Lymphoma (SLL) Means in Everyday Medical Language

Small lymphocytic lymphoma (SLL) is a type of slow-growing cancer that affects lymphocytes, which are white blood cells that help your body fight infections. In SLL, too many abnormal lymphocytes build up mainly in the lymph nodes, causing them to become larger than usual. Sometimes, these cancer cells also appear in the blood and bone marrow, and when this happens, the disease is often called chronic lymphocytic leukemia (CLL). Because of this close relationship, SLL and CLL are considered different forms of the same disease. SLL is classified as a type of non-Hodgkin lymphoma, a group of cancers that start in the lymph system.

Why SLL Can Matter in Cancer Care

Knowing that a cancer is SLL helps doctors understand how the disease might behave and what treatments could work best. SLL usually grows slowly, which means it may not need immediate treatment and can sometimes be monitored carefully before starting therapy. When treatment is needed, targeted medicines like Calquence (acalabrutinib) and Brukinsa (zanubrutinib) are options. These drugs work by blocking specific proteins that cancer cells need to survive and multiply, helping to control the disease. Because SLL is related to CLL, treatments approved for CLL often apply to SLL as well.

What Patients Might See or Hear About SLL

If you or a loved one is diagnosed with SLL, you might hear this term during discussions about diagnosis, test results, or treatment options. It may appear in medical reports, treatment plans, or drug information sheets. You might also hear about related medicines like Calquence or Brukinsa, which are targeted therapies used to treat SLL and related blood cancers. Understanding the term SLL and how it relates to CLL can help you ask your care team questions about your specific diagnosis and treatment choices.

Common Sources of Confusion and How to Read SLL in Context

The term SLL can sometimes be confusing because it is closely linked to chronic lymphocytic leukemia (CLL), and both names may appear in reports or discussions. They describe the same disease but in different locations—SLL mainly in lymph nodes and CLL mainly in blood and bone marrow. Also, SLL may be called well-differentiated lymphocytic lymphoma in some reports. Comparing the exact wording in your medical documents and asking your care team to explain what it means for your situation can help avoid misunderstandings. Remember, seeing the term SLL alone does not tell the whole story about your diagnosis or treatment plan.

How Doctors Use the Term SLL

Doctors use the term SLL to describe the type and location of the cancer during diagnosis and staging. Tests such as biopsies, blood tests, and imaging help determine whether the disease is mainly in the lymph nodes (SLL) or in the blood and bone marrow (CLL). This information guides treatment decisions and follow-up care. Because SLL is a B-cell lymphoma, it belongs to a larger group of lymphomas that affect B lymphocytes. Knowing the exact subtype helps doctors choose the best treatment approach, which may include targeted therapies, chemotherapy, or other options.

Safety and Next Steps

This information about SLL is meant to help you understand the term and its context but does not replace advice from your healthcare team. Every person’s situation is unique, and treatment decisions depend on many factors including overall health, disease stage, and previous treatments. If you see the term SLL in your medical records or hear it during your care, the best next step is to ask your doctors or nurses what it means for you personally. They can explain how it applies to your diagnosis, what treatment options are available, and what to expect going forward.